Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02119689 · ClinicalTrials.gov registry record
Vascular Reparative Mechanism in Diabetes
A clinical trial of Diabetic Retinopathy, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- 78
- Enrollment target
- 1
- Study location
NCT02119689 is a study of Diabetic Retinopathy that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 78 participants, below the 1,675-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02119689, a study of Diabetic Retinopathy, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- 78 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to study blood stem cells in diabetic patients and normal patients. We would like to better understand if these cells, called endothelial precursor cells (EPCs), are not working as expected in people with diabetes. We would like to see if the function of these cells can predict the development of diabetic retinopathy. Diabetic retinopathy is an eye disease associated with diabetes in which the cells of the retina are damaged. It can cause blurred vision, vision loss, blindness or possible bleeding in the retina. Even with current treatments, the quality of life for people with diabetic retinopathy is much reduced.
Conditions Studied
Interventions
- OTHER Diabetic Patients
- OTHER Healthy Controls
Study Locations (1)
Alabama
- University of Alabama - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2011-10-30 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02119689
The ClinicalTrials.gov registry entry for NCT02119689 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,675-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (95% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Retinopathy appearing as the primary indexed condition, and to 2 interventions - of which Diabetic Patients is the first listed.
NCT02119689 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT02119689 about?
NCT02119689 is a clinical study titled "Vascular Reparative Mechanism in Diabetes". The purpose of this research study is to study blood stem cells in diabetic patients and normal patients. We would like to better understand if these cells, called endothelial precursor cells (EPCs), are not working as expected in people with diabetes. We would like to see if the function of these c...
What is the current status of trial NCT02119689?
This trial is currently active not recruiting. The enrollment target is 78 participants. The study started on 2011-10-30. Estimated completion is 2026-12-31.
What conditions does trial NCT02119689 study?
This clinical trial studies the following conditions: Diabetic Retinopathy.
What interventions are being tested in trial NCT02119689?
The interventions under investigation include: Diabetic Patients (OTHER), Healthy Controls (OTHER).
Who is sponsoring clinical trial NCT02119689?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02119689 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Retinopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fenofibrate for Prevention of DR Worsening
RECRUITING · Phase 3
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
RECRUITING
-
Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
RECRUITING · NA
-
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
RECRUITING · Phase 2
-
Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.